1. What the evidence actually supports

Take the two modalities anchoring a lot of premium recovery suites.

Cold water immersion works, but rarely in the way operators deploy it. A 2024 systematic review and meta-analysis in the European Journal of Sport Science pooled eight studies and found that habitual post-session cold immersion after resistance training attenuated hypertrophy: adaptations in the cold group were small to negligible where training alone produced clear gains. Related meta-analytic work puts the effect on strength at a standardised mean difference near -0.60, a moderate impairment spanning one-repetition maximum, isometric strength, strength endurance and ballistic power. The proposed mechanism is suppressed anabolic signalling and reduced muscle protein synthesis.

Read that a little more carefully, because the nuance is the entire point. Cold is genuinely useful between competitive bouts, when the objective is to be functional again tomorrow. It works against you when the objective is to build capacity. Same tool, opposite outcomes, decided almost entirely by timing.

Intermittent pneumatic compression tells a quieter story. Meta-analytic work finds small but real effects on soreness and creatine kinase, and non-significant effects across most performance measures. Few trials include a placebo arm. Where they do, the picture flattens: a placebo-controlled trial in international-level youth footballers found no superiority over placebo on neuromuscular, biochemical or perceptual recovery after matches. Perceived recovery consistently outruns measured recovery, and reviewers have been explicit that current evidence does not support definitive clinical recommendation.

That is not an argument against the boots. Feeling recovered has genuine value, and adherence follows enjoyment. It is an argument against pricing ritual as physiology.

2. The cheapest input carries the largest number

Set the hardware against sleep.

RAND Europe put the cost of insufficient sleep to the US economy at $411 billion a year, 2.28% of GDP, with roughly 1.2 million working days lost annually. Moving the working population from under six hours a night to between six and seven was modelled at $226 billion in recovered output.

No device in your recovery suite has a number like that attached to it. Sleep has no vendor, no floor space, no monthly licence and no demo. It is simultaneously the least investable and the most consequential input in the entire stack, which is precisely why it loses every budget argument to a machine that photographs well.

That is the pattern worth naming: capital allocation in recovery tracks marketing sophistication, not effect size.

3. Nobody adopts a spec sheet

Here is the operational truth wellness founders and boards keep missing.

No one cares about your algorithm. They care about the human transformation on the other side of it.

What drives adoption is not pressure thresholds or thermal deltas. It is the founder three weeks from systemic burnout who rebuilt autonomic capacity and kept the business. It is the executive reclaiming a physical identity after a decade of neglect. It is the athlete returning from injury with a protocol they can name.

Technology is the engine. Narrative is the fuel. When a protocol becomes the turning point in a human story, it stops being a feature and starts being a movement.

There is a governance point buried in that, and it matters more than the marketing one. Leaders who quantify their own recovery publicly change what the organisation believes is permissible. A rostered protocol the chief executive visibly follows outperforms any wellness policy document ever written. Storytelling here is not a campaign. It is operational alignment.

4. The contrarian truth

Challenge the balance sheet.

Recovery is not just a perk, a benefit or a wellness line item. In an economy where capital is fluid and software commoditises inside a quarter, the three durable moats are cognitive bandwidth, emotional regulation and decision velocity.

Depleted leaders sadly do make expensive, reactive decisions. Recovered leaders compound enterprise value. That is not a wellness claim. It is a capital allocation claim, and it belongs in the same conversation as any other operational risk.